Advertisment Polium-B
Indian Journal of Critical Care Medicine
An open access publication of ISCCM™ 
Users online: 862 
     Home | Login 
  About Current Issue Archive Search Instructions Online Submission Subscribe Etcetera Contact  
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »  Article in PDF (396 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free) 

  IN THIS Article
 »  Abstract
 » Introduction
 » Case Report
 » Discussion
 » Conclusions
 »  References
 »  Article Tables

 Article Access Statistics
    PDF Downloaded454    
    Comments [Add]    
    Cited by others 13    

Recommend this journal


 Table of Contents    
Year : 2011  |  Volume : 15  |  Issue : 2  |  Page : 117-119

Unusual complication of aluminum phosphide poisoning: Development of hemolysis and methemoglobinemia and its successful treatment

1 Department of Forensic Toxicology, Legal Medicine Research Center, Legal Medicine Organization of Iran, Iran
2 Department of Emergency Medicine, New York University School of Medicine, NY, USA
3 Clinical Toxicology Department, Loghman Hakim Hospital Poison Center, Faculty of Medicine, and Toxicological Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Date of Web Publication16-Jul-2011

Correspondence Address:
Shahin Shadnia
Department of Clinical Toxicology, Loghman Hakim Hospital Poison Center, Faculty of Medicine, Kamali Street, South Karegar Avenue - 13334, Tehran
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0972-5229.83021

Rights and Permissions

 » Abstract 

Methemoglobinemia and hemolysis are rare findings following phosphine poisoning. In this paper, a case of aluminum phosphide (AlP) poisoning complicated by methemoglobinemia and hemolysis with a successful treatment is reported. A 28-year-old male patient presented following intentional ingestion of an AlP tablet. In this case, hematuria, hemolysis and methemoglobinemia were significant events. A methemoglobin level of 46% was detected by CO-oximetry. The patient was treated with ascorbic acid and methylene blue and he also received supportive care. Two weeks after admission, the patient was discharged from the hospital. Hemolysis and methemoglobinemia may complicate the course of phosphine poisoning.

Keywords: Aluminum phosphide, hemolysis, methemoglobinemia, phosphine, poisoning

How to cite this article:
Soltaninejad K, Nelson LS, Khodakarim N, Dadvar Z, Shadnia S. Unusual complication of aluminum phosphide poisoning: Development of hemolysis and methemoglobinemia and its successful treatment. Indian J Crit Care Med 2011;15:117-9

How to cite this URL:
Soltaninejad K, Nelson LS, Khodakarim N, Dadvar Z, Shadnia S. Unusual complication of aluminum phosphide poisoning: Development of hemolysis and methemoglobinemia and its successful treatment. Indian J Crit Care Med [serial online] 2011 [cited 2018 Jun 19];15:117-9. Available from:

 » Introduction Top

Aluminum phosphide (AlP) is an inexpensive and highly effective solid fumigant pesticide that is used in Iran. [1] Human poisoning is relatively common, and the mortality rate in Iran, as in many developing countries, is high. Mortality is often related to the absence of an effective antidote. [2]

AlP reacts with water, liberating phosphine (PH 3 ) gas. PH 3 inhibits mitochondrial oxidative phosphorylation, interferes with protein synthesis [3] and participates in free radical-induced toxicity. [4] These processes cause diffuse cellular dysfunction, leading to multiorgan failure. [5] The most consequential clinical manifestations of acute AlP poisoning are cardiovascular and respiratory. [3]

Uncommon complications following ingestion include gastroduodenitis, hepatitis, acute tubular necrosis, delayed esophageal stricture [6] and methemoglobinemia. [7]

In this article, we report a case in which the toxic effects were complicated with methemoglobinemia and hemolysis.

 » Case Report Top

A 28-year-old man with no significant past medical history was admitted to the Loghman Hakim Hospital Poison Center with a history of intentional ingestion of one tablet of AlP about 8 h prior to admission. He denied the ingestion of any other drug or intoxicant. The patient had nausea and vomiting on admission. Physical examination showed a lethargic man with the following vital signs: blood pressure (BP) 80/50 mmHg; heart rate (HR) 100 beats/min and respiratory rate (RR) 14 breaths/min. The conjunctivae were not pale and the scleras were not icteric. The general physical and neurologic examinations were not significant. As the ingestion had taken place about 8 h earlier, gastric decontamination was not performed.

Laboratory results from the emergency department are reported in [Table 1]. Arterial blood gas analysis revealed mild metabolic acidosis (pH = 7.30, PaCo 2 = 35 mmHg, HCO 3 = 20 mEq/L).
Table 1: Laboratory data of the patient during hospitalization

Click here to view

The patient was admitted in the intensive care unit (ICU) for further monitoring and supportive care. He received two 50 mEq boluses of sodium bicarbonate intravenously and 1.5 L of normal saline over 2 h. Norepinephrine was administered as a vasopressor with improvement of his BP. Along with maintenance fluids, magnesium sulfate and calcium gluconate were also administered.

Thirty hours after admission, the patient began passing dark-colored urine and was noted to be icteric. His hemoglobin concentration decreased from 14.9 g/dL to 7 g/dL during the next 24 h. Further evaluation revealed both that there was no bleeding from any site and that the patient had intravascular hemolysis. Laboratory testing included negative Coomb's direct and indirect test, reticulocyte count 17.9%, peripheral blood smear anisocytosis, poikilocytosis and schistocytosis and a normal G-6-PD activity.

The patient was treated with hydrocortisone and cross-matched packed red blood cells. Six liters of saline along with 150 mEq of sodium bicarbonate was administered per day over the next 6 days in an effort to prevent precipitation of hemoglobin in the renal tubules. The norepinephrine and electrolyte infusions were gradually stopped over the next 72 h after admission.

On the third day of admission, bluish discoloration of the periphery and cyanosis of the mucous membranes were noted. His vital signs at that time were: BP 120/80 mmHg; HR 88 beats/min; RR 35 breaths/min; the cardiovascular, respiratory and abdominal examinations were all normal. A drop in oxygen saturation in spite of high FIO 2 and tachypnea prompted intubation and mechanical ventilation.

CO-oximetry revealed a methemoglobinemia concentration of 46%. Chest radiography and electrocardiography were normal. The patient received vitamin C (1 g/q6h/IV) for 24 h because methylene blue was not available initially. Twelve hours after treatment with vitamin C, the methemoglobinemia concentration decreased to 33%. Once obtained, methylene blue (1 mg/kg of 1% solution intravenously) was administered a total of six-times. By the use of high doses of methylene blue, the methemoglobinemia concentration decreased to 23%.

On the ninth day of admission, the patient was extubated. Two weeks after admission, the laboratory data showed normalization [Table 1] and patient was transferred to the general ward. After 24 h, he was discharged from the hospital.

 » Discussion Top

Hemolysis and methemoglobinemia are the rare clinical presentations in acute AlP poisoning, and may complicate the course of this poisoning.

Jaundice due to hepatic damage may occur in a few patients with AlP poisoning. [8] This could be related to persistent hypoperfusion of the liver, although a direct toxic effect is also likely. However, in our patient, jaundice was due to intravascular hemolysis, as evidenced by a predominant indirect hyperbilirubinemia, normal liver enzymes, reticlucytosis and the presence of schistocyte in the peripheral blood smear. To date, intravascular hemolysis caused by AlP poisoning has been reported in only two patients, one of whom had G-6-PD deficiency. [9],[10]

Morphological changes in erythrocytes are reported following in vitro incubation with PH 3 gas. However, although all cells displayed crenation, and no hemolysis or Heinz body formation was noted. Thus, it is unlikely that hemolysis can be related to the direct effects of PH 3 on the erythrocytes. [11] However, PH 3 may produce lipid peroxidation that can disturb the integrity of the cells and lead to massive cell damage and death. [12]

Generalized cyanosis in the presence of normal arterial oxygen tension and the failure of the cyanosis to resolve with oxygen therapy is an important diagnostic clue, and almost always represents methemoglobinemia. [13] Diagnosis is confirmed with multiple wavelengths CO-oximetry.

PH 3 and arsine are chemically very similar and thus occurrence of methemoglobinemia by both of them is not surprising. [13] The other mechanism of action of PH 3 -induced methemoglobinemia is induction of free radicals. [14] In this case, oxidative stress may have a primary role due to the coexistence of methemoglobinemia and intravascular hemolysis.

In spite of our previous case report, [7] this patient was successfully treated by administration of vitamin C and methylene blue. One possible explanation is the physiological difference between patients or perhaps the severity of toxicity. Furthermore, ascorbic acid works slowly and generally is considered ineffective for the treatment of acute methemoglobinemia. [13] Methylene blue reduces methemoglobin to hemoglobin via the NADPH methemoglobin reductase pathway. The reason for unresponsiveness to treatment with methylene blue in our previous case [7] may be that conventional doses of methylene blue were ineffective in reducing phosphine-induced methemoglobin fractions, and it is same as other antioxidants like N-acetylcysteine. [13] In the present case, administration of vitamin C that follows by methylene blue may have a role in successful treatment. This hypothesis needs to be more evaluated in further experimental studies.

 » Conclusions Top

Jaundice in patients with AlP poisoning can be independent of hepatic damage. One should be aware of the possibility of the occurrence of intravascular hemolysis in such cases, particularly those involved in emergency care.

 » References Top

1.Mehrpour O, Singh S. Rice tablet poisoning: A major concern in Iranian population. Hum Exp Toxicol 2010;29:701-2.  Back to cited text no. 1
2.Shadnia S, Sasanian G, Allami P, Hosseini A, Ranjbar A, Amini-Shirazi N, et al. A retrospective 7-years study of aluminum phosphide poisoning in Tehran: Opportunities for prevention. Hum Exp Toxicol 2009;28:209-13.  Back to cited text no. 2
3.Perry HE. Rodenticides. In: Shannon MW, Borron SW, Burns MJ, editors. Haddad and Winchester's clinical management of poisoning and drug overdose. 4th ed. Philadelphia: W.B. Saunders Co.; 2007. p. 1218, 1225-6.  Back to cited text no. 3
4.Okolie NP, Aligbe JU, Osakue EE. Phostoxin-induced biochemical and pathomorphologiacal changes in rabbits. Indian J Exp Biol 2004;42:1096-9.  Back to cited text no. 4
5.Mehrpour O, Dolati M, Soltaninejad K, Shadnia S, Nazparvar B. Evaluation of histopathological changes in fatal aluminum phosphide poisoning. Indian J Forensic Med Toxicol 2008;2:34-6.   Back to cited text no. 5
6.Madan K, Chalamalasetty SB, Sharma M, Makharia G. Corrosive like strictures cause by ingestion of aluminum phosphide. Natl Med J India 2006;19:313-4.  Back to cited text no. 6
7.Shadnia S, Soltaninejad K, Hassanian-Moghadam H, Sadeghi A, Rahimzadeh H, Zamani N, et al. Methemoglobinemia in aluminum phosphide poisoning. Hum Exp Toxicol Toxicol 2011;30:250-3.  Back to cited text no. 7
8.Chittora MD, Meena SR, Gupta DK, Bhargava S. Acute hepatic failure in aluminum phosphide poisoning. J Assoc Physicians India 1994;42:924.  Back to cited text no. 8
9.Sood AK, Mahajan A, Dua A. Intravascular hemolysis after aluminum phosphide ingestion. J R Soc Med 1997;90:47-8.  Back to cited text no. 9
10.Aggarwal P, Handa R, Wig N, Biswas A, Saxena R, Wali JP. Intravascular hemolysis in aluminium phosphide poisoning. Am J Emerg Med 1999;17:488-9.  Back to cited text no. 10
11.Chin KL, Mai X, Meaklim J, Scollary GR, Leaver DD. The interaction of phosphine with hemoglobin and erythrocytes. Xenobiotica 1992;22:599-607.  Back to cited text no. 11
12.Chugh SN, Mittal A, Seth S, Chugh K. Lipid peroxidation in acute aluminium phosphide poisoning. J Assoc Physicians India 1995;43:265-6.  Back to cited text no. 12
13.Curry SC. Hematologic syndromes: Hemolysis, methemoglobinemia, sulfhemoglobinemia. In: Brent J, Wallace KL, Burkhart KK, Phillips S, Donovan J. editors. Critical care toxicology, diagnosis and management of the critically poisoned patient. 1st ed. Philadelphia: Elsevier Mosby Inc; 2005. p. 336-41.  Back to cited text no. 13
14.Lakshmi B. Methemoglobinemia with aluminum phosphide poisoning. Am J Emerg Med 2002;20:130-2.  Back to cited text no. 14


  [Table 1]

This article has been cited by
1 On the Protection of ALP Cardiovascular Toxicity by a Novel Mixed Herbal Medicine; Role of Oxidative Stress and Cellular ATP
Amir Baghaei,Neda Hajimohamm,Maryam Baeeri,Azadeh Mohammadir,Shokoufeh Hassani,Mohammad Abdollahi
Asian Journal of Animal and Veterinary Advances. 2014; 9(5): 302
[Pubmed] | [DOI]
2 Intravascular hemolysis after aluminum phosphide poisoning
Arefi, M. and Allahyar Parsa, V. and Yousefinejad, V. and Darvishi, N.
Indian Journal of Forensic Medicine and Toxicology. 2013; 7(1): 240-242
3 Proposing boric acid as an antidote for aluminium phosphide poisoning by investigation of the chemical reaction between boric acid and phosphine
Soltani, M. and Shetab-Boushehri, S.F. and Mohammadi, H. and Shetab-Boushehri, S.V.
Journal of Medical Hypotheses and Ideas. 2013; 7(1): 21-24
4 Proposing boric acid as an antidote for aluminium phosphide poisoning by investigation of the chemical reaction between boric acid and phosphine
Motahareh Soltani,Seyed Farid Shetab-Boushehri,Hamidreza Mohammadi,Seyed Vahid Shetab-Boushehri
Journal of Medical Hypotheses and Ideas. 2013; 7(1): 21
[Pubmed] | [DOI]
5 Environmental and Population Studies Concerning Exposure to Pesticides in Iran: A Comprehensive Review
Sara Mostafalou,Somayyeh Karami-Mohajeri,Mohammad Abdollahi
Iranian Red Crescent Medical Journal. 2013; 15(12)
[Pubmed] | [DOI]
6 A microfluidics cytometer for mice anemia detection
Ju, Y. and Song, J. and Geng, Z. and Zhang, H. and Wang, W. and Xie, L. and Yao, W. and Li, Z.
Lab on a Chip - Miniaturisation for Chemistry and Biology. 2012; 12(21): 4355-4362
7 Aluminum phosphide poisoning and development of hemolysis and methemoglobinemia
Sanaei-Zadeh, H.
Indian Journal of Critical Care Medicine. 2012; 16(4): 248-249
8 A systematic review of aluminium phosphide poisoning
Mehrpour, O. and Jafarzadeh, M. and Abdollahi, M.
Arhiv za Higijenu Rada i Toksikologiju. 2012; 63(1): 61-73
9 Response to "Blood Levels of Methemoglobin in Patients with Aluminum Phosphide Poisoning and its Correlation with Patientæs Outcome"
Sanaei-Zadeh, H.
Journal of Medical Toxicology. 2012; 8(1): 86-87
10 A Systematic Review of Aluminium Phosphide Poisoning
Omid Mehrpour,Mostafa Jafarzadeh,Mohammad Abdollahi
Archives of Industrial Hygiene and Toxicology. 2012; 63(1)
[Pubmed] | [DOI]
11 A microfluidics cytometer for mice anemia detection
Yanrui Ju,Jian Song,Zhaoxin Geng,Hongze Zhang,Wei Wang,Lide Xie,Weijuan Yao,Zhihong Li
Lab on a Chip. 2012; 12(21): 4355
[Pubmed] | [DOI]
12 Response to “Blood Levels of Methemoglobin in Patients with Aluminum Phosphide Poisoning and its Correlation with Patient’s Outcome”
Hossein Sanaei-Zadeh
Journal of Medical Toxicology. 2012; 8(1): 86
[Pubmed] | [DOI]
13 Effects of hyperbaric oxygenation on survival time of aluminum phosphide intoxicated rats
Saidi, H., Shokraneh, F., Ghafouri, H.-B., Shojaie, S.
Journal of Research in Medical Sciences. 2011; 16(10): 1306-1312


Print this article  Email this article
Online since 7th April '04
Published by Wolters Kluwer - Medknow